Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Pharmacology of Oral Nicotine Pouches
NCT07829939Phase 1Not yet recruiting
- Sponsor
- University of California, San Francisco
- Start
- Oct 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Phase 1, randomised trial of nicotine (4 arms), sponsored by University of California, San Francisco. Primary endpoint: Titration of nicotine intake to be similar to or higher than that seen with cigarette smoking or vaping. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
nicotine
Beyond the preview
Go deeper on NCT07829939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07829939.